1.• Multiple sclerosis, the prototypical inflammatory demyelinating disease of the central nervous system, is second only to trauma as a cause of acquired neurologic disability…

Review 1460 www.thelancet.com Vol 385 April 11, 2015 IgG4-related disease Terumi Kamisawa, Yoh Zen, Shiv Pillai, John H Stone IgG4-related disease is a protean condition…

Slide 1 Slide 1 of 26 Emerging Therapies for Multiple Sclerosis Slide 2 Slide 2 of 26 Newly Identified Players in the Pathophysiology of Multiple Sclerosis Suhayl Dhib-Jalbut,…

Phenotyping Optimization of T cell expansion in a perfusion bioreactor Clive Glover PhD Product Leader, Cell Bioprocessing â¹#⺠/ GE / Perspective Scaling UP? Scaling…

Jordan et al. BMC Medicine 2013, 11:120 http://www.biomedcentral.com/1741-7015/11/120 REVIEW Open Access Abstract Conventional immunosuppressive therapies have radically

Successful therapy with rituximab in three patients with probable neurosarcoidosisjournals.sagepub.com/home/tan 1 DOI: 10.1177/ 1756286418805732 Creative Commons Non Commercial